Myles Wolf

23PUBLICATIONS
56CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Infant and child healthHaematologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 12, 2026
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.

Benjamin Catanese, Cameron Miller, Myles Wolf

|Mar 11, 2026
Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial.

Benjamin Catanese, Mark Heise, Anna M Chang

|Feb 05, 2026
Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.

Farzana Perwad, Matthew B Matheson, Eva Glenn Lecea

|Jul 10, 2025
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.

Daniel Edmonston, Tamara Isakova, Laura M Dember

|May 13, 2025
Effects of Lowering Dietary Phosphorus Additive Intake on Mineral Metabolism in Adults with and without CKD.

Muhammad Bilal Khan, Mercedes R Carnethon, Tamara Isakova

|Feb 05, 2025
Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.

Brendon L Neuen, Benjamin Catanese, Annamarie Chang

Pageof 4